Skip to main content

Table 2 Outcomes of nephrotoxicity in patients who received PIPC/TAZ and CFPM

From: Higher incidence of acute kidney injury in patients treated with piperacillin/tazobactam than in patients treated with cefepime: a single-center retrospective cohort study

Outcomes

PIPC/TAZ (n = 163)

CFPM (n = 103)

p-value

Acute kidney injury, n (%)

14 (8.6)

1 (0.9)

 

Odds ratio [95% CI]

9.53 [1.41 – 408]

reference

0.011

AKIN grade

 stage 1, n

12

1

 

 stage 2, n

2

0

 

 stage 3, n

0

0

 

Discontinuation or change of antibiotics

0

0

-

Initiation of dialysis

0

0

-

  1. CI Confidence interval, AKIN Acute Kidney Injury Network